title: Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer.
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: David
authors.initials: D
authors.lastname: Lorente
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Diletta
authors.initials: D
authors.lastname: Bianchini
authors.affiliation: Guy's and St. Thomas NHS Foundation Trust, United Kingdom.
authors.forename: Alejo
authors.initials: A
authors.lastname: Rodriguez-Vida
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Aurelius
authors.initials: A
authors.lastname: Omlin
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Carmel
authors.initials: C
authors.lastname: Pezaro
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Roberta
authors.initials: R
authors.lastname: Ferraldeschi
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Andrea
authors.initials: A
authors.lastname: Zivi
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.
authors.forename: Gerhardt
authors.initials: G
authors.lastname: Attard
authors.affiliation: Guy's and St. Thomas NHS Foundation Trust, United Kingdom.
authors.forename: Simon
authors.initials: S
authors.lastname: Chowdhury
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: Johann.De-Bono@icr.ac.uk.
authors.forename: Johann S
authors.initials: JS
authors.lastname: De Bono
mesh_terms: D000737:Androstenols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000737:Androstenols; D043823:Taxoids; D010669:Phenylthiohydantoin